Quanterix Corp (QTRX) Stock Price, Quote & News

Company Profile

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all comp...

Industry: Medical Devices

Sector: Healthcare

Phone: 617 301 9400

Website: www.quanterix.com

Address:

Building 1, 900 Middlesex Turnpike, Billerica, United States

Stockelroy May. 12 at 7:25 PM

$QTRX loading up here at $2.99 post 52 week low recently… looking strong and chatter beginning to chatter 💪

0 · Reply

PLATINUM_TRADES May. 12 at 7:15 PM

$QTRX I told u let's break $3.00👇👇👇👇 please... Nobody seen this.... Thank you for the free money

0 · Reply

PLATINUM_TRADES May. 11 at 2:13 PM

$QTRX 62 straight without a loss..... Small profits here but green 🥗 🥗

1 · Reply

PLATINUM_TRADES May. 11 at 8:11 AM

$QTRX Let's break$3.00 please 🌞

0 · Reply

Oxinternet May. 9 at 8:31 PM

$QTRX Someone bought 72,000 shares after hours on Friday.

0 · Reply

vmst1 May. 8 at 1:33 AM

$QTRX Ameriprise Financial has been selling a total of about 4 million shares on days ending on April 30,2026. Ameriprise has only 990,224 shares now. Selling pressure like this sinks the price. Perhaps other institutional/hedge funds also lightened their holdings. The valuation is so depressed now that it should attract buy out offers which may or may not be satisfactory to QTRX BOD. https://www.sec.gov/Archives/edgar/data/1503274/000119312526210789/xslSCHEDULE_13G_X02/primary_doc.xml

1 · Reply

Will2ride1 May. 7 at 3:35 PM

$QTRX luckily sold my position 2 days ago, but man what a hit...may consider jumping back in...watching for now

0 · Reply

SQUEAKSBANDIT May. 7 at 1:46 PM

$QTRX based on the chart someone new this was coming.......whats new???

0 · Reply

SQUEAKSBANDIT May. 7 at 1:42 PM

$QTRX was there any mention of future strategic transactions? or if they would be interested in selling/merging/partnering ? right now market is not buying

0 · Reply

sakuzoh May. 7 at 1:36 PM

$QTRX how low is this gonna go what the hell

0 · Reply

Quanterix announces CFO transition

May 12, 2026, 4:01 PM EDT - 16 hours ago

Quanterix Announces Planned Transition of Chief Financial Officer

2026-05-07T20:14:51.000Z - 5 days ago

Quanterix price target lowered to $4 from $7 at TD Cowen

2026-05-07T06:21:33.000Z - 6 days ago

Lucent Diagnostics announces collaboration with Tempus AI

TEM

2026-05-07T01:49:19.000Z - 6 days ago

Quanterix reports Q1 EPS (37c), consensus (62c)

2026-05-07T01:48:11.000Z - 6 days ago

Quanterix affirms 2026 revenue outlook $169M-$174M

May 6, 2026, 4:30 PM EDT - 6 days ago

Quanterix Earnings Call Transcript: Q1 2026

May 6, 2026, 4:01 PM EDT - 6 days ago

Quanterix Releases Financial Results for the First Quarter of 2026

May 6, 2026, 8:00 AM EDT - 7 days ago

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

TEM

Apr 24, 2026, 8:33 AM EDT - 19 days ago

Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

2026-04-20T14:08:55.000Z - 22 days ago

Quanterix price target lowered to $4 from $8 at Canaccord

2026-04-17T12:56:49.000Z - 25 days ago

Quanterix, PreludeDX highlights AidaBREAST multi-omic assay

Apr 17, 2026, 8:33 AM EDT - 26 days ago

AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology

2026-04-15T12:40:49.000Z - 27 days ago

Quanterix debuts Content Innovation Engine at AACR 2026

Apr 15, 2026, 8:33 AM EDT - 4 weeks ago

Quanterix Debuts Content Innovation Engine at AACR 2026

Mar 27, 2026, 4:00 PM EDT - 6 weeks ago

Quanterix Corporation Announces Date of 2026 Annual Meeting

Mar 9, 2026, 1:00 PM EDT - 2 months ago

Quanterix Transcript: Leerink Global Healthcare Conference 2026

Mar 4, 2026, 11:50 AM EST - 2 months ago

Quanterix Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 4:30 PM EST - 2 months ago

Quanterix Earnings Call Transcript: Q4 2025

2026-03-02T21:06:31.000Z - 2 months ago

Quanterix reports Q4 EPS (49c) vs. (30c) last year

2026-03-02T21:05:34.000Z - 2 months ago

Quanterix sees FY26 revenue $169M-$174M, consensus $168.8M

Mar 2, 2026, 4:01 PM EST - 2 months ago

Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025

Mar 2, 2026, 8:33 AM EST - 2 months ago

Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide

Feb 26, 2026, 8:33 AM EST - 2 months ago

Quanterix to Participate in Upcoming Investor Conferences

Feb 20, 2026, 8:33 AM EST - 2 months ago

Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

2026-02-03T14:25:10.000Z - 3 months ago

Quanterix submits FDA 510(k) for Alzheimer’s disease blood test

Feb 3, 2026, 8:33 AM EST - 3 months ago

Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection

Jan 21, 2026, 8:33 AM EST - 3 months ago

Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling

Jan 16, 2026, 4:01 PM EST - 4 months ago

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-01-08T21:36:14.000Z - 4 months ago

Quanterix names Everett Cunningham president, CEO

Jan 8, 2026, 4:30 PM EST - 4 months ago

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

2025-12-22T12:35:19.000Z - 5 months ago

Quanterix publishes Simoa p-Tau 217 assay study in Nature

Dec 22, 2025, 7:30 AM EST - 5 months ago

Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence

2025-12-22T12:06:46.000Z - 5 months ago

Quanterix price target raised to $8 from $5 at Canaccord

2025-11-20T21:21:00.000Z - 6 months ago

Quanterix names Bill Donnelly executive chair

Nov 20, 2025, 4:15 PM EST - 6 months ago

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Nov 17, 2025, 5:30 PM EST - 6 months ago

Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring

Nov 10, 2025, 4:30 PM EST - 6 months ago

Quanterix Earnings Call Transcript: Q3 2025

2025-11-10T21:05:38.000Z - 6 months ago

Quanterix reports Q3 EPS (73c), consensus (53c)

Nov 10, 2025, 4:01 PM EST - 6 months ago

Quanterix Releases Financial Results for the Third Quarter of 2025

Nov 3, 2025, 7:00 AM EST - 6 months ago

Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025

2025-09-10T13:41:01.000Z - 8 months ago

CMS fee schedule a ‘meaningful positive’ for Quanterix, says Leerink

Aug 21, 2025, 4:30 PM EDT - 9 months ago

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

Aug 13, 2025, 3:30 PM EDT - 9 months ago

Quanterix Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 11, 2025, 7:00 AM EDT - 9 months ago

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

2025-08-11T08:55:15.000Z - 9 months ago

Quanterix downgraded to Hold from Buy at Canaccord

Aug 7, 2025, 4:30 PM EDT - 9 months ago

Quanterix Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:06 PM EDT - 9 months ago

Quanterix Releases Financial Results for the Second Quarter of 2025

Aug 4, 2025, 4:02 PM EDT - 10 months ago

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

2025-08-04T13:35:07.000Z - 10 months ago

Quanterix announces cooperation agreement with Kent Lake Capital

Aug 4, 2025, 9:30 AM EDT - 10 months ago

Quanterix Announces Cooperation Agreement with Kent Lake Capital

2025-07-28T11:25:06.000Z - 10 months ago

Quanterix announces commercial launch of two novel phospho-tau assays

Jul 28, 2025, 7:00 AM EDT - 10 months ago

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Jul 8, 2025, 9:07 AM EDT - 11 months ago

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

Jun 23, 2025, 7:30 AM EDT - 11 months ago

Quanterix Expands Reach with IVD and Large Reference Labs

Jun 11, 2025, 8:00 AM EDT - 1 year ago

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Jun 9, 2025, 1:20 PM EDT - 1 year ago

Quanterix Transcript: Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 6, 2025, 9:41 AM EDT - 1 year ago

Quanterix to Present at Goldman Sachs Global Healthcare Conference

May 23, 2025, 2:21 PM EDT - 1 year ago

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

AKYA

May 12, 2025, 4:30 PM EDT - 1 year ago

Quanterix Earnings Call Transcript: Q1 2025

May 12, 2025, 4:01 PM EDT - 1 year ago

Quanterix Releases Financial Results for the First Quarter of 2025

May 7, 2025, 3:46 PM EDT - 1 year ago

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

AKYA

May 5, 2025, 7:00 AM EDT - 1 year ago

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

AKYA

Apr 29, 2025, 7:00 AM EDT - 1 year ago

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

AKYA

Apr 17, 2025, 8:30 AM EDT - 1 year ago

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

AKYA

Apr 7, 2025, 8:15 AM EDT - 1 year ago

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

AKYA

Apr 1, 2025, 1:00 AM EDT - 1 year ago

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Quanterix Earnings Call Transcript: Q4 2024

Mar 17, 2025, 4:01 PM EDT - 1 year ago

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Mar 17, 2025, 4:00 PM EDT - 1 year ago

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

AKYA

Mar 13, 2025, 1:00 PM EDT - 1 year ago

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Mar 11, 2025, 8:00 AM EDT - 1 year ago

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Mar 3, 2025, 8:00 AM EST - 1 year ago

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Mar 3, 2025, 6:00 AM EST - 1 year ago

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Stockelroy May. 12 at 7:25 PM

$QTRX loading up here at $2.99 post 52 week low recently… looking strong and chatter beginning to chatter 💪

0 · Reply

PLATINUM_TRADES May. 12 at 7:15 PM

$QTRX I told u let's break $3.00👇👇👇👇 please... Nobody seen this.... Thank you for the free money

0 · Reply

PLATINUM_TRADES May. 11 at 2:13 PM

$QTRX 62 straight without a loss..... Small profits here but green 🥗 🥗

1 · Reply

PLATINUM_TRADES May. 11 at 8:11 AM

$QTRX Let's break$3.00 please 🌞

0 · Reply

Oxinternet May. 9 at 8:31 PM

$QTRX Someone bought 72,000 shares after hours on Friday.

0 · Reply

vmst1 May. 8 at 1:33 AM

1 · Reply

Will2ride1 May. 7 at 3:35 PM

$QTRX luckily sold my position 2 days ago, but man what a hit...may consider jumping back in...watching for now

0 · Reply

SQUEAKSBANDIT May. 7 at 1:46 PM

$QTRX based on the chart someone new this was coming.......whats new???

0 · Reply

SQUEAKSBANDIT May. 7 at 1:42 PM

$QTRX was there any mention of future strategic transactions? or if they would be interested in selling/merging/partnering ? right now market is not buying

0 · Reply

sakuzoh May. 7 at 1:36 PM

$QTRX how low is this gonna go what the hell

0 · Reply

Shane_Drinion May. 7 at 12:57 PM

$QTRX Still not ready for primetime.

1 · Reply

Rufusbird May. 6 at 11:00 PM

$QTRX Just listened to the conference call. Cunningham has hit his stride. He is confident and knowledgeable. He impressed me on this call. They plan to bring in a new seasoned marketing pro. This should be an event to wait for as the company recovers from the expense and begins to benefit from the Akoya acquisition and new business relationships etc.

1 · Reply

StocktwitsEarnings May. 6 at 8:15 PM

$QTRX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.37 up 30.19% YoY • Reported revenue of $36.41M up 20.05% YoY • Quanterix reaffirms 2026 revenue guidance of $169 million to $174 million, with GAAP gross margin anticipated between 41% and 45%. Quanterix expects to achieve cash flow breakeven in the second half of 2026, ending the year with $100M cash.

0 · Reply

SQUEAKSBANDIT May. 6 at 5:39 PM

$QTRX earnings this evening? you guys holding through ?

0 · Reply

Precision3ntries May. 6 at 12:08 PM

Watching : $EZGO $GCTK $AHMA $BCG 📈 $QTRX

0 · Reply

Stock_Catcher May. 6 at 12:06 PM

$QTRX Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows

0 · Reply

Pika_Capital Apr. 30 at 7:08 PM

$QTRX watching closely. This has a potential for 5x return if they can turn things around in 2026

2 · Reply

Rufusbird Apr. 30 at 1:44 PM

$QTRX Classic Shakeout. They shook the margin call bell. Glad my shares are all paid for.

0 · Reply

sakuzoh Apr. 29 at 5:08 PM

$QTRX wow I can’t believe it went that low on no news

0 · Reply

SQUEAKSBANDIT Apr. 26 at 5:39 PM

$QTRX is there value in the merged company or will it just keep drifting lower somewheres b/t a buck and two next year ? noticed vanguard sold their entire position

1 · Reply

Stormvyre Apr. 25 at 6:25 AM

$QTRX Upcoming Q1 Earnings: Quanterix is scheduled to report its First Quarter 2026 financial results on May 6, 2026, after the market closes.

0 · Reply

SQUEAKSBANDIT Apr. 24 at 6:34 PM

$QTRX off the lows on very light volume seems as if the shorts took the day

0 · Reply

Market Cap	131.90M
Revenue (ttm)	138.90M
Net Income (ttm)	-107.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-77.14%
Debt to Equity Ratio	0.00

Volume	1,644,600
Avg Vol	1,065,202
Day's Range	N/A - N/A
Shares Out	47.11M
Stochastic %K	34%
Beta	1.15
Analysts	Hold
Price Target	$4.33